Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, Diplomate American Board of Intrnal Medicine
Internal Medicine Specialist
M.B.B.S., M.R.C.P. (Medicine)
General Physician
M.B.B.S, MCPS (Family Medicine)
Cardiologist
MBBS, ECFMG, FLEX, Diplomate American Board of Internal Medicine , Diplomate American Board of Cardiovascular Disease, Certification Board of Nuclear Cardiology, FCCP, FACP, FACC
Cardiologist
MBBS, ECFMG, FLEX, Diplomate American Board of Internal Medicine , Diplomate American Board of Cardiovascular Disease, Certification Board of Nuclear Cardiology, FCCP, FACP, FACC
Gastroenterologist
M.B.B.S, M.D (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
MBBS, FCPS (Medicine), FCPS (Gastroenterology), MRCP (LONDON) UK, European specialty examination in gastroenterology & Hepatology (ESG&H)
Gastroenterologist
MBBS, FCPS (Medicine), FCPS (Gastroenterology), MRCP (LONDON) UK, European specialty examination in gastroenterology & Hepatology (ESG&H)
Consultant Physician
MBBS, FCPS(Medicine), MD(USA), FCPS (Fellow DM Endocrinology& Metabolism)
Consultant Physician
MBBS, FCPS(Medicine), MD(USA), FCPS (Fellow DM Endocrinology& Metabolism)
Internal Medicine Specialist
M.B.B.S., F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures